6HF5 image
Deposition Date 2018-08-21
Release Date 2018-12-05
Last Version Date 2024-01-17
Entry Detail
PDB ID:
6HF5
Keywords:
HYDROLASE
Title:
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-431 Inhibitor
Biological Source:
Source Organism:
Pseudomonas aeruginosa (Taxon ID: 287)
Host Organism:
Escherichia coli BL21(DE3)
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.80 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
I 2 2 2
6HF5 validation report
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Beta-lactamase class B VIM-2
Gene (Uniprot):blaVIM-2
Chain IDs:A
Chain Length:231
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
UniProt ID:Q9K2N0 Pfam ID:PF00753 EC:3.5.2.6
Ligand Molecules
ACT
G1N
ZN
Primary Citation
SAR Studies Leading to the Identification of a Novel Series of Metallo-beta-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
Acs Infect Dis. 5 131 140 (2019)
PMID: 30427656 DOI: 10.1021/acsinfecdis.8b00246

Abstact

The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
5MXQ
5MXR
Feedback Form
Name
Email
Institute
Feedback